The story of Sildenafil presents a interesting case for investors in the medicinal sector. While initially a blockbuster success, producing vast sums, the intellectual property lapse and the subsequent flood of cheaper https://knockoff687522.frewwebs.com/40545792/viagra-and-big-pharma-a-risky-bet